Sélectionner une page

Lateral flow tests are performed by people who do not have symptoms of COVID-19. Anyone who develops 1 of the top 3 symptoms of COVID-19 should stay home, self-isolate and get a PCR test. They must self-isolate if they test positive, even if they recently had a negative lateral flow test – these rules have not changed. Short turnaround time for NAAT-COP tests, but little available Analysis by NHS Test and Trace shows that LFD tests have an estimated specificity of at least 99.97% when used in the community. This means that for every 10,000 lateral flow tests performed, there are probably fewer than 3 false positives. LFD tests identify the most contagious people. These people tend to transmit the virus to many people, so it remains important to identify them. Table 1 summarizes some characteristics of NAAT and antigen tests to consider for a screening program. Given the risk of transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals infected with SARS-CoV-2, the use of antigen testing in asymptomatic and presymptomatic individuals may be considered. The FDA has provided a list of FAQs for health care providers who use diagnostic tests to screen asymptomatic individuals, and the Centers for Medicare & Medicaid Services will temporarily exercise its enforcement discretion to allow the use of antigen tests in asymptomatic individuals for the duration of the COVID-19 public health emergency under the 1988 Clinical Laboratory Improvement Amendments. (CLIA).

Laboratories testing for SARS-CoV-2 must hold a CLIA certificate and meet regulatory requirements. Tests that have received an EUA from the FDA for point-of-care (POC) use can be performed with a CLIA exemption certificate. Screening is recommended for specific groups to protect the most vulnerable and support clinical care, and only these groups are eligible for free testing. A virus test tells you if you are infected with SARS-CoV-2, the virus that causes COVID-19. There are two types of tests for the virus: rapid tests and laboratory tests. Virus tests use samples that come out of your nose or mouth. Rapid tests can be done within minutes and may contain antigens and some NAATs. Laboratory tests can take days and include RT-PCR and other types of NAAT.

Some test results may require confirmatory testing. *The reduced sensitivity of antigen tests may be compensated if POC antigen tests are repeated more frequently (i.e., at least weekly serial tests). ^ Cost of: NAATexternal symbol +Applies to point-of-care antigen testing only. The CDC has updated its isolation and quarantine recommendations for the public. These recommendations do not apply to medical personnel and do not replace national, local, tribal or territorial laws, rules and regulations. Read the CDC press release. After all, around one million people in England who are particularly at risk of becoming seriously ill with COVID-19 have been identified by the NHS as potentially suitable for new treatments. They will receive a PCR test kit at home by mid-January, which they can use if they develop symptoms or test positive for LFD, as they may be eligible for new treatments if they test positive for PCR. This group should use these priority PCR tests if they have symptoms, as this allows for priority laboratory manipulation. COVID-19 tests can detect either SARS-CoV-2, the virus that causes COVID-19, or the antibodies your body makes after contracting COVID-19 or after vaccination. Screening tests are recommended for unvaccinated individuals to identify those who are asymptomatic and have no known, suspected or reported exposure to SARS-CoV-2.

Screening helps identify unknown cases so that steps can be taken to prevent transmission. When deciding which test to use, it is important to understand the purpose of the test (diagnosis or screening), how to perform the test in the context of the level of community transmission, the need for rapid results, and other considerations (see Table 1). For example, even a very specific antigen test may have a low positive predictive value (high number of false positives) when used in a community with a low prevalence of infection. Another example is the use of laboratory NAAT in a community with high transmission and increased testing needs, which can result in delays in diagnosis due to treatment time and the time required to return results. The positive and negative predictive values of NAAT and antigen tests vary depending on the probability before the test. The pre-test probability takes into account both the prevalence of the degree of transmission in the community and the clinical setting of the person being tested. Additional information on sensitivity, specificity, positive and negative predictive values for antigen and antibody tests, and the relationship between pre-test probability and probability of positive and negative predictive values icon pdf [458 KB, 1 page] is available. See also FDA letters to clinical laboratory staff and healthcare providers about the potential for false-positive results with antigen tests and the potential for false-negative results with molecular tests when a genetic variant of SARS-CoV-2 occurs in the portion of the viral genome evaluated by the test.

You should not collect tests at a pharmacy if you have symptoms. You should order online or ask someone who has no symptoms to collect lateral flow tests on your behalf. Many categories of tests are used to detect SARS-CoV-2,1 and their performance characteristics vary. Antibody tests (or serology) are used to detect previous SARS-CoV-2 infection and can help diagnose multisystem inflammatory syndrome in children (MIS-C) and adults (MIS-A)2. The CDC does not recommend the use of antibody tests to diagnose a current infection. Depending on when a person was infected and when the test was tested, the test may not detect antibodies in a person with a current infection.